Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002019805 | SCV002284447 | likely pathogenic | not provided | 2022-02-27 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 442 of the SLC12A3 protein (p.Asn442Lys). This variant is present in population databases (rs775232139, gnomAD 0.01%). This missense change has been observed in individual(s) with Gitelman syndrome (PMID: 18581727, 33024574). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC12A3 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Fulgent Genetics, |
RCV005017044 | SCV005639244 | likely pathogenic | Familial hypokalemia-hypomagnesemia | 2024-03-27 | criteria provided, single submitter | clinical testing |